May 14, 2026 08:35 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Vijay-led TVK wins Tamil Nadu floor test as AIADMK split plays out | Congress veteran Sonia Gandhi admitted to Medanta Hospital in Gurugram | PM Modi halves convoy size after austerity call | Mulayam Singh's younger son Prateek Yadav dies at 38 | Protests erupt in Delhi after NEET UG 2026 cancellation over alleged paper leak | AIADMK cracks widen after Tamil Nadu defeat; faction backs Vijay-led TVK government | Himanta Biswa Sarma takes oath as Assam CM for second term after BJP’s landslide win | Bengali rights activist Garga Chatterjee arrested over alleged provocative remarks ahead of assembly polls | No return to full WFH yet: IT firms unlikely to change hybrid work model despite PM Modi’s appeal | Suvendu Adhikari Cabinet clears BSF land transfer, census rollout, Ayushman Bharat in Bengal

CMA wants Health Canada, not industry, to design marijuana labelling

| @indiablooms | Feb 08, 2018, at 05:27 pm

Ottawa, Feb 8 (IBNS): Designing marijuana packaging and product labelling --  an important way to educate consumers, especially young people about the risks of using marijuana --  should be left to federal officials and public health experts, not cannabis producers and distributors, said The Canadian Medical Association (CMA) recently.

Product labels are a key factor of educating consumers, especially young people, about the risks of pot, according to  (CMA), media reports said.

Health Canada -- responsible for helping Canadians maintain and improve their health and ensures accessibility of high-quality health services and works to reduce health risks -- had been applying different levels of scrutiny to prescription drugs.

Consumers of recreational marijuana had been stressing the need to be protected from misleading health claims and want a single set of regulations in place for both the medical and recreational marijuana industry, media reports said.

"Ensuring that health products are safe and effective must be a key component of any regulations on cannabis," said  Dr. Laurent Marcoux, the president  of CMA,,on Monday.

"This is why we believe rigorous scientific evidence is needed to support claims of health benefits and to identify potential risks and adverse reactions."

CMA, a voluntary group that represents most of the country's physicians, had been urging Ottawa to apply the same standards to marijuana as it does to prescription medication and prohibit health claims that are not backed by research.

Recreational marijuana is expected to be legalized by federal government this summer.


(Reporting by Asha Bajaj)

Image: Marijuana: CMA Facebook page.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.